Speakers will include: Commissioner Dalli, Permanent Representatives, MEPs, Chairs of the Alliance.
The meeting will address the following key policy areas:
Ensuring a regulatory environment which allows early patient access to novel and efficacious personalised medicine
Increasing research and development for personalised medicine
Improving the education and training of healthcare professionals
Acknowledging new approaches to reimbursement and HTA assessment, which are required for patient access to personalised medicine and its value to be recognised
Increasing awareness and understanding of personalised medicine
When
September 18th, 2012 6:00 PM through 7:30 PM
Contact
Email: info@ecpc-online.org
